Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis
Titel:
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis
Auteur:
Buckstein, Rena Kerbel, Robert Cheung, Matthew Shaked, Yuval Chodirker, Lisa Lee, Christina R. Lenis, Martha Davidson, Cindy Cussen, Mary-Anne Reis, Marciano Chesney, Alden Zhang, Liying Mamedov, Alexandre Wells, Richard A.